Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New salary data for cardiologists, surgeons & more | Same-day PPMI after TAVR | Early rhythm control in high-risk patients
Monday, August 4, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Salary update: Cardiologist compensation stays steady—thoracic surgeon pay takes a hit

Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Salary update: Cardiologist compensation stays steady—thoracic surgeon pay takes a hit

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 
READ MORE >

Exploring the value of same-day permanent pacemaker implantation after TAVR

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Exploring the value of same-day permanent pacemaker implantation after TAVR

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 
READ MORE >

Early rhythm control boosts AFib outcomes for patients with obesity, diabetes

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

READ MORE >
doctorwithpatient.jpg
Share on Twitter Share on Facebook Share on Linkedin

Early rhythm control boosts AFib outcomes for patients with obesity, diabetes

Share on Twitter Share on Facebook Share on Linkedin
doctorwithpatient.jpg
Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.
READ MORE >

Featured Articles

Pilot study looks at same-day discharge PCI for acute coronary syndromes

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients. 

READ MORE >
Interventional cardiologists performing PCI
Share on Twitter Share on Facebook Share on Linkedin

Pilot study looks at same-day discharge PCI for acute coronary syndromes

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologists performing PCI
Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients. 
READ MORE >

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.

READ MORE >
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Share on Twitter Share on Facebook Share on Linkedin

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Share on Twitter Share on Facebook Share on Linkedin
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.
READ MORE >

The most anticipated trials at ESC 2025

The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.

READ MORE >
The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.ESC Congress 2022 European Society of Cardiology. #ESC #ESC2025 #ESC25
Share on Twitter Share on Facebook Share on Linkedin

The most anticipated trials at ESC 2025

Share on Twitter Share on Facebook Share on Linkedin
The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.ESC Congress 2022 European Society of Cardiology. #ESC #ESC2025 #ESC25
The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.
READ MORE >

In Case You Missed It

What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis

President Donald Trump has been diagnosed with chronic venous insufficiency. He underwent a complete evaluation due to swelling in his legs, the White House announced, and is in “excellent health” otherwise. 

READ MORE >
President Donald Trump, White House press photo.
Share on Twitter Share on Facebook Share on Linkedin

What is chronic venous insufficiency? Cardiologist shares perspective on President Trump’s diagnosis

Share on Twitter Share on Facebook Share on Linkedin
President Donald Trump, White House press photo.
President Donald Trump has been diagnosed with chronic venous insufficiency. He underwent a complete evaluation due to swelling in his legs, the White House announced, and is in “excellent health” otherwise. 
READ MORE >

AHA data challenge explores links between inflammation and heart disease

Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others. 

READ MORE >
The American Heart Association (AHA) has launched a nationwide data-driven research competition to uncover how inflammation contributes to cardiovascular risk and how it is currently addressed in clinical practice. The initiative, called the Systemic Inflammation Data Challenge, invites data scientists, clinicians, and researchers to leverage advanced analytics and electronic medical record (EMR) data to better understand the impact of systemic inflammation on atherosclerotic cardiovascular disease.
Share on Twitter Share on Facebook Share on Linkedin

AHA data challenge explores links between inflammation and heart disease

Share on Twitter Share on Facebook Share on Linkedin
The American Heart Association (AHA) has launched a nationwide data-driven research competition to uncover how inflammation contributes to cardiovascular risk and how it is currently addressed in clinical practice. The initiative, called the Systemic Inflammation Data Challenge, invites data scientists, clinicians, and researchers to leverage advanced analytics and electronic medical record (EMR) data to better understand the impact of systemic inflammation on atherosclerotic cardiovascular disease.
Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others. 
READ MORE >

First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve

A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve

Share on Twitter Share on Facebook Share on Linkedin
A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.
READ MORE >

In Other News

Yale names new radiology chair, Rad Partners’ board addition, plus more leadership moves from ASTRO, Merit Medical

Christopher Whitlow, MD, is the Ivy League institution's new radiology leader, while John Chiminski joins the RP board, and Catheryn M. Yashar, MD, is set to become ASTRO president. 

READ MORE >
Christopher Whitlow, MD, PhD, MHA Yale
Share on Twitter Share on Facebook Share on Linkedin

Yale names new radiology chair, Rad Partners’ board addition, plus more leadership moves from ASTRO, Merit Medical

Share on Twitter Share on Facebook Share on Linkedin
Christopher Whitlow, MD, PhD, MHA Yale
Christopher Whitlow, MD, is the Ivy League institution's new radiology leader, while John Chiminski joins the RP board, and Catheryn M. Yashar, MD, is set to become ASTRO president. 
READ MORE >

New details surrounding fatal Long Island MRI accident prompt more questions

New information indicates Nassau Open MRI has closed circuit video cameras throughout its facility, including in the control room of the MRI trailer attached to the building where the accident took place. 

READ MORE >
MRI safety zone warning sign at entrance into an MRI imaging room at Northwestern Central DuPage Hospital.
Share on Twitter Share on Facebook Share on Linkedin

New details surrounding fatal Long Island MRI accident prompt more questions

Share on Twitter Share on Facebook Share on Linkedin
MRI safety zone warning sign at entrance into an MRI imaging room at Northwestern Central DuPage Hospital.
New information indicates Nassau Open MRI has closed circuit video cameras throughout its facility, including in the control room of the MRI trailer attached to the building where the accident took place. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup